The global undecylenic acid market size is likely to be valued at US$3.5 billion in 2026 and is projected to reach US$4.8 billion by 2033, growing at a CAGR of 4.7% during the forecast period from 2026 to 2033, driven by surging demand for bio-based ingredients in personal care, a rise in topical antifungal medications, and expanding applications in specialty polymers such as Nylon-11.

Driver – Established Regulatory Recognition as an Over-the-Counter Antifungal Active Ingredient

Regulatory recognition of undecylenic acid as a safe and effective topical antifungal active ingredient is a significant driver for the market, supporting sustained demand across pharmaceutical and personal care formulations. The U.S. Food and Drug Administration (FDA), permits the use of undecylenic acid and its calcium, copper, and zinc salts in over-the-counter topical antifungal drug products under Monograph M005. The combined concentration of undecylenates must range between 10% and 25%. This established regulatory framework provides manufacturers with a clear pathway for developing and marketing antifungal formulations.

Restraint – Volatility in Castor Oil Feedstock Supply and Pricing

Undecylenic acid is derived from castor oil through pyrolysis of ricinoleic acid, making the market highly dependent on castor seed supply conditions that are subject to significant agricultural volatility. Castor cultivation remains heavily concentrated in India, which accounts for the large majority of global castor oil exports, and reporting has noted that unfavorable monsoon conditions have driven double-digit swings in national castor seed production estimates in recent years, directly affecting downstream feedstock costs for derivatives including undecylenic acid.

Opportunity – Growing Demand for Natural, Bio-Based Cosmetic Preservatives

Tightening cosmetic ingredient regulations and rising consumer preference for clean-label formulations represent a meaningful opportunity for undecylenic acid as a naturally derived cosmetic biocide and preservative alternative. Proposed amendments to the European Union’s Cosmetics Regulation (EC) No. 1223/2009 continue to tighten restrictions on certain synthetic preservatives. These regulatory changes are encouraging cosmetic manufacturers to adopt plant-derived alternatives such as undecylenic acid. Undecylenic acid is already used as a cosmetic biocide and surfactant in natural personal care formulations.

Form Insights

Liquid undecylenic acid is expected to lead the form segment, accounting for about 42% of total form revenue in 2026, given its established role in topical antifungal solutions, industrial biocide applications, and its use as a chemical intermediate for downstream derivatives.

Cream formulations are likely to be the fastest-growing form. Their widespread use in antifungal skincare products and medicated personal care formulations continues to support increasing demand.

Application Insights

Antifungal agent applications are estimated to dominate the application segment, representing around 38% of total application revenue in 2026, supported by undecylenic acid’s long-established status as an FDA-recognized over-the-counter active ingredient for skin fungal infections.

Cosmetic biocide applications are likely to be the fastest-growing application segment. Growing consumer preference for clean-label formulations and naturally derived antimicrobial ingredients is further accelerating demand for undecylenic acid in cosmetic applications.

Sales Channel Insights

Direct sales are forecast to lead the sales channel segment, accounting for about 46% of total sales channel revenue in 2026, reflecting the preference of pharmaceutical, cosmetic, and specialty chemical manufacturers for bulk procurement through established supplier relationships.

Third-party online channels are likely to be the fastest-growing sales channel; the expansion of specialty chemical distributors and laboratory reagent suppliers on e-commerce platforms is further improving product availability and market reach.

North America Undecylenic Acid Market Trends

North America is estimated to hold approximately 29% of global undecylenic acid market share in 2026. Regional growth is supported by sustained OTC antifungal drug manufacturing under FDA Monograph M005, along with the rising demand for natural cosmetic ingredients across the personal care industry.

U.S. Undecylenic Acid Market Trends

The U.S. is expected to account for nearly 84% of North America market revenue in 2026, driven by established pharmaceutical-grade undecylenic acid demand and the presence of leading specialty chemical suppliers, including Thermo Fisher Scientific, Cayman Chemical, and MP Biomedicals.

Europe Undecylenic Acid Market Trends

Europe is estimated to capture around 26% of global market revenue in 2026. The region’s growth is shaped by tightening cosmetic preservative regulations, sustained demand for natural and bio-based personal care ingredients, and the presence of leading castor oil derivatives manufacturers with extensive European operations.

Germany, U.K., and France Undecylenic Acid Market Trends

Germany is forecast to lead Europe with about 24% of regional market share in 2026, reflecting its position as home to established chemical and life sciences suppliers including Merck KGaA. The U.K. and France follow as key markets, supported by growing clean-label cosmetic formulation demand and expanding pharmaceutical-grade fine chemical production across both countries.

Asia Pacific Undecylenic Acid Market Trends

Asia Pacific is forecast to dominate the global market, commanding nearly 35% of total market share in 2026, and is also the fastest-growing region, growing at a CAGR of approximately 5.8% from 2026 to 2033. The region leads due to its position as the world’s primary castor oil feedstock base and its expanding specialty chemical and cosmetic ingredient manufacturing capacity.

China Undecylenic Acid Market Trends

China is anticipated to lead with over 31% of Asia Pacific market share in 2026, powered by its strong pharmaceutical manufacturing base and expanding production of topical antifungal formulations. Increasing exports of active pharmaceutical ingredients (APIs) and growing domestic personal care manufacturing are further strengthening market demand.

The global undecylenic acid market is moderately fragmented, comprising established specialty chemical manufacturers alongside fine chemical and laboratory reagent suppliers. Competition is shaped by product purity grade, regulatory compliance documentation, castor oil feedstock sourcing reliability, and the ability to serve pharmaceutical, cosmetic, and industrial customers across multiple formulation grades.

Key competitive dynamics include continued investment in sustainable and traceable castor oil sourcing programs, expansion of pharmaceutical- and cosmetic-grade production capacity, and strategic initiatives aimed at strengthening long-term feedstock supply chain resilience amid ongoing castor seed price volatility.

Key Industry Developments:

• In June 2026, Parchem highlighted the expanding applications of undecylenic acid, emphasizing its role as a castor oil-derived antifungal ingredient in pharmaceutical, cosmetic, and agricultural formulations, while underscoring ongoing innovation in sustainable product development.